Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study

Eslam Safwat; Manar Salah; Hany Hussein

doi:10.1016/j.ajg.2020.08.003

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Eslam, S., Manar, S., Hany, H. (2020). Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2020.08.003

Jamil S. Samaan; Yee Hui Yeo; Wee Han Ng; Peng-Sheng Ting; Hirsh Trivedi; Aarshi · 2023

cites

390

Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver…

Xiaotong Xu; Jinglan Jin; Yuwei Liu · 2023

cites

394

Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery syste…

Aya Abdelghany; Mohamed A. El-Desouky; Mohamed Shemis · 2021

cites

388

Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patient…